Are you Dr. Libraty?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Department Of Infectious Disease
Worcester, MA 01655Phone+1 508-856-4182
Summary
- Dr. Daniel Libraty, MD is an infectious disease specialist in Worcester, Massachusetts. He is currently licensed to practice medicine in Massachusetts, California, and Colorado. He is affiliated with Saint Francis Memorial Hospital and is an Associate Professor at University Massachusetts Medical School.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 1993 - 1996
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1989 - 1992
- University of California San Diego School of MedicineClass of 1989
Certifications & Licensure
- CA State Medical License 2020 - 2026
- MA State Medical License 2002 - 2025
- CO State Medical License 2020 - 2021
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Prospective Study of Infant Dengue Start of enrollment: 2006 Sep 01
Publications & Presentations
PubMed
- 1303 citationsHost defense mechanisms triggered by microbial lipoproteins through toll-like receptors.Hans Brightbill, Daniel H. Libraty, Stephan R. Krutzik, Ruey-Bing Yang, John T. Belisle
Science. 1999-07-30 - 31 citationsUnderstanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Co...Nusrat J Epsi, Stephanie A Richard, David A Lindholm, Katrin Mende, Anuradha Ganesan
Clinical Infectious Diseases. 2023-02-08 - 488 citationsHigh circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic feverDaniel H. Libraty, Paul R. Young, Darren Pickering, Timothy P. Endy, Siripen Kalayanarooj
The Journal of Infectious Diseases. 2002-10-15
Grant Support
- Mechanisms Of Vascular Leakage In Viral Hemorrhagic FeversNational Institute Of Allergy And Infectious Diseases2009–2012
- A Study Of Heterologous Immunity Induced By Neonatal BCG VaccinationNational Institute Of Allergy And Infectious Diseases2011
- A Clinical Study Of Protective And Pathogenic Immunity To Dengue During InfancyNational Institute Of Allergy And Infectious Diseases2011
- A Study Of Protective Immunity Against Dengue In InfantsNational Institute Of Allergy And Infectious Diseases2005–2009
- Hantavirus: Hemorrhagic Fever ImmunopathogenesisNational Institute Of Allergy And Infectious Diseases2008
- Cellular Immune Response To The SARS Human CoronavirusNational Institute Of Allergy And Infectious Diseases2004–2005